Today we're speaking with Keren Leshem. Keren Leshem is the CEO of OCON Healthcare that focuses on women's health, primarily creating high-quality intrauterine drug delivery solutions. OCON is innovating in areas that have not been touched for three decades. Furthermore, Keren is very active in the FemTech ecosystem as a whole.
00:55 What was your journey that brought you into this market of pharma, MedTech and drug delivery? And why did it begin abroad?
02:59 What does OCON do?
06:31 Why did you build OCON with a female majority? Is there any difference in managing a company that is predominantly female on a day-to-day basis?
09:23 Do you think that you need to be a woman to lead a FemTech company?
10:40 What are seeing is changing in the FemTech space? What do you expect will happen looking forward?
16:47 When did you feel that OCON’s solution is really unique?
22:44 What did you find when you joined the company in 2018? And what did you do to turn it around?
26:40 You mentioned you found a way to recruit patients inexpensively during COVID. Can you tell us a little bit about how you did this?
33:23 Do you do any promotion to the end-user using social media?
34:49 Where does the world of direct-to-consumer or at least consumer-centric marketing live in your vision going forward for OCON?
38:40 What would you say to those people that say that using social media and LinkedIn is only applicable to MedTech companies that are already in the market?
42:28 What tips you would give to up-and-coming CEOs in the MedTech space if they can contact you for advice and mentorship?
46:51 Could you elaborate a little bit on your volunteer work with Michla’la? How did you get involved with that?
Today we're speaking with Keren Leshem. Keren Leshem is the CEO of OCON Healthcare that focuses on women's health, primarily creating high-quality intrauterine drug delivery solutions. OCON is innovating in areas that have not been touched for three decades. Furthermore, Keren is very active in the FemTech ecosystem as a whole.
00:55 What was your journey that brought you into this market of pharma, MedTech and drug delivery? And why did it begin abroad?
02:59 What does OCON do?
06:31 Why did you build OCON with a female majority? Is there any difference in managing a company that is predominantly female on a day-to-day basis?
09:23 Do you think that you need to be a woman to lead a FemTech company?
10:40 What are seeing is changing in the FemTech space? What do you expect will happen looking forward?
16:47 When did you feel that OCON’s solution is really unique?
22:44 What did you find when you joined the company in 2018? And what did you do to turn it around?
26:40 You mentioned you found a way to recruit patients inexpensively during COVID. Can you tell us a little bit about how you did this?
33:23 Do you do any promotion to the end-user using social media?
34:49 Where does the world of direct-to-consumer or at least consumer-centric marketing live in your vision going forward for OCON?
38:40 What would you say to those people that say that using social media and LinkedIn is only applicable to MedTech companies that are already in the market?
42:28 What tips you would give to up-and-coming CEOs in the MedTech space if they can contact you for advice and mentorship?
46:51 Could you elaborate a little bit on your volunteer work with Michla’la? How did you get involved with that?